Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantation.
Florent MalardAonghus LavelleGiorgia BattipagliaBéatrice GauglerRémy DuleryEolia BrissotClémence MediavillaSarah JegouNathalie RolhionTounes LedraaRazan MohtyHarry SokolMohamad MohtyPublished in: Mucosal immunology (2021)
Patients receiving allogeneic hematopoietic cell transplantation (alloHCT) were previously shown to display a bacterial gut dysbiosis; however, limited data are available regarding the role of fungal microbiota in these patients. We evaluated the bacterial and fungal composition of the fecal microbiota at day 0 of alloHCT. Higher bacterial diversity was associated with an improved overall survival (OS) and disease-free survival (DFS). While fungal diversity had no impact on patient outcomes, we observed that high versus low relative abundance of Candida albicans in alloHCT patients at day 0 was associated with a significantly lower OS, DFS and graft-versus-host-free, relapse-free survival (GRFS) (p = 0.0008, p = 0.0064 and p = 0.026, respectively). While these results are limited by low patient numbers and low fungal read counts in some samples, they suggest a potentially important role for C albicans in alloHCT.
Keyphrases
- free survival
- candida albicans
- stem cell transplantation
- end stage renal disease
- bone marrow
- cell wall
- biofilm formation
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- peritoneal dialysis
- single molecule
- hematopoietic stem cell
- peripheral blood
- machine learning
- deep learning
- patient reported outcomes